EUVIMEDEUVIMED entdecken
Crossref

Recent Progress and Future Potential for Novel Metal Complexes as Antibreast Cancer Drugs

Abdou Saad El-Tabl, Moshira Mohamed Abd El-Wahed, Sameh Anwer Zawam Mohamed, Mohamed S. Abd El-Khalek, Omnya Ebrahim Abd El-Wahab

Scientific Research Journal of Medicine · 30.12.2021 · 1 (1) · 1-10

DOI: 10.47310/srjme.2021.v01i01.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientific Research Journal of Medicine, online erschienen am 30.12.2021. Verfasst von Abdou Saad El-Tabl und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Now most effective chemotherapeutic agents in treatment of breast cancer (MCF-7) have several/major drawbacks such as cumulative toxicities of nephrotoxicity and ototoxicity or treatment induced resistance. This has provided the motivation for devoloping novel metal complexes as antibreast cancer. In recent years, significant attention has been devoted in this direction. Cr (III), Mn (II), Ni (II), Cu (II), Zn (II) and Ca (II), complexes of (E) -2-((1-(5-acetyl-2,4-dihydroxyphenyl) ethylidene) amino) benzoic acid were prepared and characterized by elemental analyses, IR, UV-Vis spectra, Magnetic moments, Conductivity, 1H-NMR, Elctron microscope and Mass spectra, Thermal analyses (DTA and TGA) and ESR measurements. The analytical and IR data showed that, the ligand behaves as neutral or monobasic trior pentadentade. Molar conductivity in DMF indicate that, the complexes are non-electrolytes. Electron microscopic Data showed, the complexes are found in nano-form, ESR spectra of solid Cu(II) complexes at room temperature show axial type (dx2-y2) with covalent bond character in an octahedral environment. However, Mn (II) complex showed isotropic type. Complexes showed inhibitory activity against breast cancer (MCF-7 cell line) compared with standard drug. Ca (II) complex 8 demonstrated high potency inhibition activity against MCF-7 cell line with IC50 76 no toxic effect was observed (invivo studies).

Zitieren

APA

El-Tabl, A. S., El-Wahed, M. M. A., Mohamed, S. A. Z., El-Khalek, M. S. A., & El-Wahab, O. E. A. (2021). Recent Progress and Future Potential for Novel Metal Complexes as Antibreast Cancer Drugs. Scientific Research Journal of Medicine, 1(1), 1-10. https://doi.org/10.47310/srjme.2021.v01i01.006

Vancouver

El-Tabl AS, El-Wahed MMA, Mohamed SAZ, El-Khalek MSA, El-Wahab OEA. Recent Progress and Future Potential for Novel Metal Complexes as Antibreast Cancer Drugs. Scientific Research Journal of Medicine. 2021;1(1):1-10. doi:10.47310/srjme.2021.v01i01.006

BibTeX
@article{ElTabl2021,
  author = {El-Tabl, Abdou Saad and El-Wahed, Moshira Mohamed Abd and Mohamed, Sameh Anwer Zawam and El-Khalek, Mohamed S. Abd and El-Wahab, Omnya Ebrahim Abd},
  title = {Recent Progress and Future Potential for Novel Metal Complexes as Antibreast Cancer Drugs},
  journal = {Scientific Research Journal of Medicine},
  year = {2021},
  volume = {1},
  number = {1},
  pages = {1--10},
  doi = {10.47310/srjme.2021.v01i01.006}
}
Kostenlos starten →